Literature DB >> 11819366

Presence of Fas and Bcl-2 proteins in BEL-7404 human hepatoma cells.

Xing-Wang Wang, Hong Xie.   

Abstract

AIM:To study the expression of Fas and Bcl-2 proteins in BEL-7404 human hepatoma cells in order to analyze the possible relationship between cell growth regulation by alpha-fetoprotein(AFP) and Fas/Bcl-2 proteins.
METHODS: BEL-7404 human hepatoma cells were maintained in RPMI 1640 medium supplemented with 10% new-born calf serum. Cells adhered to coverslips were used to detect Fas and Bcl-2 protein expression by the avidin-biotin complex (ABC) immunocytochemical assay.
RESULTS: Immunocytochemical study showed that essentially all the BEL-7404 human hepatoma cells could express Fas and Bcl-2 proteins, although in various amount. No positive staining for Fas and Bcl-2 proteins was observed when cells were incubated with non-relevant sera, to establish the specificity.
CONCLUSION: Fas apoptosis signals and Bcl-2 rescue/survival signals from apoptosis are expressed in BEL-7404 human hepatoma cells. The finding strongly implys that AFP-mediated cell apoptosis and growth enhancement are potentially associated with Fas and Bcl-2 proteins present in those cells.

Entities:  

Year:  1998        PMID: 11819366      PMCID: PMC4723449          DOI: 10.3748/wjg.v4.i6.540

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  13 in total

1.  Induction of apoptosis in human hepatoma cells by alpha-fetoprotein.

Authors:  L N Semenkova; E I Dudich; I V Dudich
Journal:  Tumour Biol       Date:  1997

Review 2.  alpha-fetoprotein as a biologic response modifier: relevance to domain and subdomain structure.

Authors:  G J Mizejewski
Journal:  Proc Soc Exp Biol Med       Date:  1997-09

3.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

4.  Cell death studies yield cancer clues.

Authors:  J Marx
Journal:  Science       Date:  1993-02-05       Impact factor: 47.728

5.  Growth-regulative activity of human alpha-fetoprotein for different types of tumor and normal cells.

Authors:  E Dudich; L Semenkova; E Gorbatova; I Dudich; L Khromykh; E Tatulov; G Grechko; G Sukhikh
Journal:  Tumour Biol       Date:  1998

Review 6.  [Several transcription factors participate in the functioning of the alpha-fetoprotein gene promoter].

Authors:  B Bois-Joyeux; H Thomassin; F Richard; R Ikonomova; M Denissenko; J L Danan
Journal:  Bull Cancer       Date:  1995-07       Impact factor: 1.276

7.  Nuclear oncogenes and alpha-fetoprotein gene expression in hepatoma cell lines.

Authors:  I Tournier-Thurneyssen; G Feldmann; D Bernuau
Journal:  Tumour Biol       Date:  1993

Review 8.  Apoptosis. Its significance in cancer and cancer therapy.

Authors:  J F Kerr; C M Winterford; B V Harmon
Journal:  Cancer       Date:  1994-04-15       Impact factor: 6.860

9.  [Mutation of p53 gene and expression of alphafetoprotein during hepatocarcinogenesis].

Authors:  H Q Zou; Z Y Tang; S L Ye
Journal:  Zhonghua Yi Xue Za Zhi       Date:  1994-08

Review 10.  Bcl-2 and the regulation of programmed cell death.

Authors:  J C Reed
Journal:  J Cell Biol       Date:  1994-01       Impact factor: 10.539

View more
  10 in total

1.  Early apoptosis in intestinal and diffuse gastric carcinomas.

Authors:  Hong-Ping Zhou; Xu Wang; Nan-Zheng Zhang
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

2.  Expression of regulating apoptosis gene and apoptosis index in primary liver cancer.

Authors:  Hong-Yu Xu; You-Lin Yang; Xi-Li Guan; Guang Song; Ai-Min Jiang; Li-Jun Shi
Journal:  World J Gastroenterol       Date:  2000-10       Impact factor: 5.742

Review 3.  Current gene therapy for stomach carcinoma.

Authors:  C T Xu; L T Huang; B R Pan
Journal:  World J Gastroenterol       Date:  2001-12       Impact factor: 5.742

4.  Induction of apoptosis by TPA and VP-16 is through translocation of TR3.

Authors:  Su Liu; Qiao Wu; Xiao-Feng Ye; Jian-Huai Cai; Zhi-Wei Huang; Wen-Jin Su
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

5.  Intravenous chemotherapy for resected gastric cancer: meta-analysis of randomized controlled trials.

Authors:  Jian-Kun Hu; Zhi-Xin Chen; Zong-Guang Zhou; Bo Zhang; Jing Tian; Jia-Ping Chen; Li Wang; Chao-Hua Wang; Hong-Yan Chen; You-Ping Li
Journal:  World J Gastroenterol       Date:  2002-12       Impact factor: 5.742

6.  Effect of arsenic trioxide on human hepatoma cell line BEL-7402 cultured in vitro.

Authors:  Hong-Yu Xu; You-Lin Yang; Yuan-Yuan Gao; Qiao- Li Wu; Guang-Qiang Gao
Journal:  World J Gastroenterol       Date:  2000-10       Impact factor: 5.742

7.  Telomerase inhibition and telomere loss in BEL-7404 human hepatoma cells treated with doxorubicin.

Authors:  Ru-Gang Zhang; Li-Xia Guo; Xing-Wang Wang; Hong Xie
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

8.  Hypermethylation of growth arrest DNA damage-inducible gene 45 beta promoter in human hepatocellular carcinoma.

Authors:  Weihua Qiu; Bingsen Zhou; Hongzhi Zou; Xiyong Liu; Peiguo G Chu; Richard Lopez; Jennifer Shih; Christopher Chung; Yun Yen
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

9.  Study of apoptosis in human liver cancers.

Authors:  Chang-Min Shan; Juan Li
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

10.  Fas counterattack in cholangiocarcinoma: a mechanism for immune evasion in human hilar cholangiocarcinomas.

Authors:  Z Y Li; S Q Zou
Journal:  World J Gastroenterol       Date:  2001-12       Impact factor: 5.742

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.